Streetbeat News

Products Services

AMZN

FDX

UPS

Amazon has reactivated its external shipping service, Amazon Shipping, to compete with FedEx and UPS. The service is available to vendors on Amazon's platform across the contiguous U.S. Amazon has also committed to delivering packages in less than a day by 2023. The company has been reducing its dependency on third-party carriers like UPS and FedEx by expanding its logistics network. Amazon's shares traded higher by 0.90% in the premarket.

Portfolio Pulse from Anusuya Lahiri

August 21, 2023 | 12:31 pm

GILD

Gilead Sciences has announced a partial clinical hold for its Magrolimab studies in Acute Myeloid Leukemia (AML). However, patients already enrolled may continue receiving the study medicine and studies in solid tumors remain unaffected.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 12:31 pm

NIO

Chinese electric vehicle manufacturer, Nio Inc, is increasing the production of its ES6 model after a five-day pause. The company's factory in Hefei, Anhui province, is now producing at least 300 ES6 vehicles daily, with some workshops transitioning to double-shift production schedules. This increase in production is in response to a temporary production line halt at Nio’s F1 plant from July 29 to Aug. 2, aimed at upgrading the manufacturing process. Despite the disruptions, Nio delivered a record-breaking 20,462 vehicles in July.

Portfolio Pulse from Ramakrishnan M

August 21, 2023 | 12:28 pm

PHAT

Phathom Pharmaceuticals has submitted six-month stability data for its Erosive GERD New Drug Application (NDA) for vonoprazan. The data remains more than 10x below the acceptable intake limit set by the FDA, supporting the requested product shelf life. This submission satisfies Phathom's stability data submission requirements for the NDA, with a PDUFA goal date of November 17, 2023.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 12:14 pm

ENVB

Enveric Biosciences (NASDAQ:ENVB) has completed the manufacturing of its drug material, EB-373, enabling the completion of preclinical work. The company will now commence remaining GLP studies to provide data required to initiate human trials for EB-373. The company expects to complete all remaining preclinical studies required for Human Research Ethics Committee (HREC) submission in Australia before the end of 2023. The high purity of EB-373 allows Enveric and its partners to handle and ship the drug without restrictions required for controlled substances.

Portfolio Pulse from Happy Mohamed

August 21, 2023 | 12:13 pm

ONFO

Onfolio has announced the launch of its new AI-driven tool, 'Get Quick'. The tool is designed to help users make faster and more informed decisions.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 12:04 pm

ANEB

Anebulo Pharmaceuticals has received positive feedback from the FDA regarding the advancement of Phase 3 clinical development of ANEB-001. The company has also completed dosing of Phase 2 extension.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 12:04 pm

GERN

The FDA has accepted Geron Corporation's new drug application for Imetelstat, a treatment for lower risk Myelodysplastic Syndromes (MDS).

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 12:02 pm

EDBL

Edible Garden has received a notice of allowance for a US patent for its self-watering display. The company's innovative technology could potentially revolutionize the way plants are grown and maintained, providing a significant competitive advantage.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 12:01 pm

OGI

Organigram Holdings Inc. is relaunching its cannabis brand Trailblazer with a portfolio of new products including THCV gummies, CBG infused pre-rolls, and a high-potency pre-roll. The company plans to introduce additional products in the upcoming fiscal year. The relaunch is aimed at creating a positive and uplifting experience for consumers.

Portfolio Pulse from Vuk Zdinjak

August 21, 2023 | 11:50 am